In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

THERE is a growing need to raise awareness about the effectiveness of generic drugs amid the increasing cost of healthcare. A 2022 survey by the UCSI Poll Research Centre survey involving 1,060 ...

Entresto generics have finally arrived in the U.S. in July, and approximately 9% of Novartis' revenue will be impacted. The growth of other key products and of Entresto in ex-U.S. territories should ...

Generic drugs are cheaper copies of brand drugs, offering significant savings to patients. Once a brand-name drug's patent expires, competitors can apply to make generic versions. Generic ...

The Food and Drug Administration on Tuesday quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions. That makes the drug, from the company Evita ...

The decision enraged opponents of abortion, who have been pressuring the Trump administration to restrict access to abortion medication. By Pam Belluck The Food and Drug Administration has approved a ...

The settlement agreement will extend market exclusivity for AbbVie’s JAK inhibitor in the U.S. until 2037—providing pediatric exclusivity is granted. AbbVie has reached a settlement with generic ...

A new analysis from GoodRx explores how 2025 is shaping up for Food and Drug Administration drug approvals, and the early data tells a mixed story. Importantly, a growing disconnect remains between ...

Generic brands, sometimes referred to as "private label" or "store brands," are increasingly popular today as shoppers face rising food prices in grocery stores. Some consumers believe these brands to ...

A revolution is coming in the U.S. generics marketplace, one that players in the space ignore at their peril. This revolution has the potential to transform savvy organizations into engines of growth, ...